You just read:

Bird Rock Bio Completes Single Ascending Dose Human Clinical Trial for Namacizumab; Generates Safety, Tolerability, and Pharmacokinetics Data; Prepares To Initiate Study in Non-Alcoholic Fatty Liver Disease Patients

News provided by

Bird Rock Bio, Inc.

Jun 05, 2017, 08:00 ET